BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 20733117)

  • 21. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study.
    Luo J; Margolis KL; Wactawski-Wende J; Horn K; Messina C; Stefanick ML; Tindle HA; Tong E; Rohan TE
    BMJ; 2011 Mar; 342():d1016. PubMed ID: 21363864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
    Slanger TE; Chang-Claude JC; Obi N; Kropp S; Berger J; Vettorazzi E; Braendle W; Bastert G; Hentschel S; Flesch-Janys D
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1188-96. PubMed ID: 19336542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chocolate Candy and Incident Invasive Cancer Risk in the Women's Health Initiative: An Observational Prospective Analysis.
    Greenberg JA; Neuhouser ML; Tinker LF; Lane DS; Paskett ED; Van Horn LV; Wassertheil-Smoller S; Shikany JM; Qi L; Sealy-Jefferson S; Manson JE
    J Acad Nutr Diet; 2021 Feb; 121(2):314-326.e4. PubMed ID: 32763064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for ductal and lobular breast cancer: results from the nurses' health study.
    Kotsopoulos J; Chen WY; Gates MA; Tworoger SS; Hankinson SE; Rosner BA
    Breast Cancer Res; 2010; 12(6):R106. PubMed ID: 21143857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
    Lænkholm AV; Jensen MB; Eriksen JO; Roslind A; Buckingham W; Ferree S; Nielsen T; Ejlertsen B
    Clin Breast Cancer; 2020 Aug; 20(4):e423-e432. PubMed ID: 32253134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second primary breast cancer occurrence according to hormone receptor status.
    Kurian AW; McClure LA; John EM; Horn-Ross PL; Ford JM; Clarke CA
    J Natl Cancer Inst; 2009 Aug; 101(15):1058-65. PubMed ID: 19590058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
    Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Alcohol Consumption on Breast Cancer Incidence and Mortality: The Women's Health Study.
    Mostofsky E; Lee IM; Buring JE; Mukamal KJ
    J Womens Health (Larchmt); 2024 Jun; 33(6):705-714. PubMed ID: 38417039
    [No Abstract]   [Full Text] [Related]  

  • 29. Alcohol consumption and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.
    Kabat GC; Kim M; Shikany JM; Rodgers AK; Wactawski-Wende J; Lane D; Powell L; Stefanick ML; Freiberg MS; Kazlauskaite R; Chlebowski RT; Wassertheil-Smoller S; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2066-72. PubMed ID: 20647412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active smoking and breast cancer risk: original cohort data and meta-analysis.
    Gaudet MM; Gapstur SM; Sun J; Diver WR; Hannan LM; Thun MJ
    J Natl Cancer Inst; 2013 Apr; 105(8):515-25. PubMed ID: 23449445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.
    Calle EE; Feigelson HS; Hildebrand JS; Teras LR; Thun MJ; Rodriguez C
    Cancer; 2009 Mar; 115(5):936-45. PubMed ID: 19156895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study.
    Cui Y; Shikany JM; Liu S; Shagufta Y; Rohan TE
    Am J Clin Nutr; 2008 Apr; 87(4):1009-18. PubMed ID: 18400726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
    Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
    Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of breast cancer associated with specific patterns of migraine history.
    Lowry SJ; Malone KE; Cushing-Haugen KL; Li CI
    Cancer Causes Control; 2014 Dec; 25(12):1707-15. PubMed ID: 25359301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
    Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
    Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for stage IV breast cancer at the time of presentation in Turkey.
    Uyeturk U; Tatli AM; Gucuk S; Oksuzoglu B; Ulas A; Avci N; Ozbay MF; Gunduz S; Akinci MB; Salim DK; Sonmez OU; Akdag F; Ergenc H
    Asian Pac J Cancer Prev; 2013; 14(12):7445-9. PubMed ID: 24460317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
    Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.
    Li CI; Daling JR; Tang MT; Haugen KL; Porter PL; Malone KE
    JAMA Intern Med; 2013 Sep; 173(17):1629-37. PubMed ID: 23921840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.